BeiGene Announces Inclusion of Three Innovative Oncology Products in China National Reimbursement Drug List (NRDL)
The Pharma Data
DECEMBER 27, 2020
With these NRDL inclusions, BeiGene is making significant strides towards our mission, which at its core is to expand access to and improve affordability of impactful innovative medicines for patients around the world. Celgene Logistics Sàrl, a Bristol Myers Squibb (BMS) company, and EUSA Pharma. QARZIBA ® ? Carfilzomib.
52 
Let's personalize your content